Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011. - Test2 - elhamkhani - TriplyDB

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

http://www.wikidata.org/entity/Q30367631

about

Genetic and antigenic characterization of influenza A(H3N2) in Cameroon during the 2014-2016 influenza seasons.

P2860

Q40055695-3C82889E-1B75-4546-B0A0-FE0EF2B2EB22

P2860

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

http://www.wikidata.org/entity/Q30367631

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@ast

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@en

type

label

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@ast

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@en

prefLabel

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@ast

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

@en

P1433

Q30367631-9B6F08EB-EA97-4856-86C9-20DAEA6298A4

P1476

Q30367631-EC776330-E7DA-454A-B574-FA252CDC4173

P2093

Q30367631-1069D652-DDA0-4733-87CB-7DBAEE841AC5

Q30367631-4A9B9304-D929-4C31-B33E-05B2E2BFD6AF

Q30367631-4B98E5D3-3CC8-44DF-8295-7BF991B77369

Q30367631-68702357-1450-4055-BB16-7E6282181900

Q30367631-70FD7E01-1AE2-46CF-BAE2-25D5C1535C3F

Q30367631-74B823B2-885D-4CDC-8FEB-1C69A933345F

Q30367631-78783A98-ADD9-41D9-8C48-F10C0B24834E

Q30367631-8A747DD8-E014-465E-8094-86AD1D028F86

Q30367631-98AF0B53-2577-4DC5-9F90-1A83FF313330

Q30367631-9EBFFBB0-81D1-40A3-B00A-47C9A6D15576

P2860

Q30367631-045BE5F3-BBE3-4319-906E-374125CDF964

Q30367631-04C192FB-C436-458D-A411-0A401D37A972

Q30367631-057E28ED-3688-45C5-9FE1-B9B87194EF22

Q30367631-0CA45BCA-4292-49EB-B0A9-7BFE3BD10B4F

Q30367631-16F1C522-D6D4-421E-ACCB-1E221CEC7E5F

Q30367631-1D6BB5B5-3678-477D-9A2D-A91589EB9635

Q30367631-20532BA8-C773-4BAB-9FC4-FD3413C1B6CA

Q30367631-20657F79-5B26-4891-A0A5-15A8B32C270D

Q30367631-2522CE73-051E-4C4D-97FC-14EC034CCEA1

Q30367631-34C0A435-064E-425A-8CE0-69D2FA59990C

P304

Q30367631-B0A6DF26-5421-4F1B-A326-FFF78CBE5741

P31

Q30367631-548C7973-1C2E-4F97-B94C-A501A93C6D44

P407

Q30367631-53B7E9B4-D078-432D-968A-0CD7FBE4BFFA

P433

Q30367631-7BA032D3-2A6A-4B56-802B-A9B8B9B54925

P478

Q30367631-CE761C8D-50C1-4193-95F8-F2E8AD771F97

P50

Q30367631-779FAD9B-D054-4516-A382-ABA74E492003

P577

Q30367631-8A67BF9D-1181-4854-980D-C4B4AC9771C8

P698

Q30367631-9D5E5DF7-3BE8-462E-8357-12886540903E

P932

Q30367631-A6B6B3D7-389E-4C35-B82C-DFB2AB909E23

P1433

Indian Journal of Medical Research

P1476

Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011

@en

P2093

A A Kadam

http://www.w3.org/2001/XMLSchema#string

A C Mishra

http://www.w3.org/2001/XMLSchema#string

D Bishwas

http://www.w3.org/2001/XMLSchema#string

K N Patil

http://www.w3.org/2001/XMLSchema#string

M Chawla-Sarkar

http://www.w3.org/2001/XMLSchema#string

M R Dakhave

http://www.w3.org/2001/XMLSchema#string

M S Chadha

http://www.w3.org/2001/XMLSchema#string

P B Kulkarni

http://www.w3.org/2001/XMLSchema#string

P Gunashekaran

http://www.w3.org/2001/XMLSchema#string

S A Tikhe

http://www.w3.org/2001/XMLSchema#string

P2860

MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

Oseltamivir resistance during treatment of influenza A (H5N1) infection

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries.

Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08

Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010-11.

Recovery of drug-resistant influenza virus from immunocompromised patients: a case series.

Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment?

Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.

P304

244-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

140

http://www.w3.org/2001/XMLSchema#string

P50

Asha Mary Abraham

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25297358

http://www.w3.org/2001/XMLSchema#string

P932

4216499

http://www.w3.org/2001/XMLSchema#string